Level Financial Advisors, Inc. Amgen Inc Transaction History

Level Financial Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 18, 2023	BUY	$218.65 - $271.46 $21,865 - $27,145	100 Added 135.14%	174 $46,000
Q1 2023 Apr 10, 2023	SELL	$225.79 - $275.2 $677 - $825	-3 Reduced 3.9%	74 $17,000
Q4 2022 Jan 23, 2023	BUY	$229.03 - $291.01 $687 - $873	3 Added 4.05%	77 $0
Q1 2022 Apr 08, 2022	SELL	$219.27 - $242.57 $21,927 - $24,257	-100 Reduced 57.47%	74 $18,000
Q4 2021 Jan 20, 2022	BUY	$198.88 - $227.6 $34,605 - $39,602	174 New	174 $39,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $151B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Level Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Level Financial Advisors, Inc. with notifications on news.